Cardio Diagnostics Holdings, Inc. (CDIO)
NASDAQ: CDIO · Real-Time Price · USD
2.040
+0.030 (1.49%)
At close: Aug 14, 2026, 4:00 PM EDT
2.020
-0.020 (-0.98%)
After-hours: Aug 14, 2026, 7:52 PM EDT
CDIO Market Cap
CDIO has a market cap or net worth of $6.04 million as of August 14, 2026. Its market cap has decreased by -9.10% in one year.
Market Cap
6.04M
Enterprise Value
820.32K
1-Year Change
-9.10%
Ranking
Category
Stock Price
$2.04
ChartMarket Cap Chart
Since July 26, 2022, CDIO's market cap has decreased from $368.96M to $6.04M, a decrease of -98.36%. That is a compound annual growth rate of -63.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 6.04M | 22.00% |
| Dec 31, 2025 | 4.95M | -86.66% |
| Dec 31, 2024 | 37.08M | -27.41% |
| Dec 29, 2023 | 51.09M | 406.54% |
| Dec 30, 2022 | 10.09M | -97.27% |
| Jul 26, 2022 | 368.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Evogene | 6.48M |
| Bolt Biotherapeutics | 6.42M |
| Curanex Pharmaceuticals | 6.41M |
| Purple Biotech | 6.25M |
| PharmaCyte Biotech | 6.08M |
| NuCana | 6.03M |
| Addex Therapeutics | 5.94M |
| BioRestorative Therapies | 5.93M |